A lead investor in a German biotech company that is working on a coronavirus vaccine has issued a statement saying that it should be available anywhere , without mentioning US President Donald Trump . 
The comments by Dietmar Hopp , the main investor in Cure Vac , come after the company denied a report that Trump was trying to lure its scientists to the US in a statement Sunday . 
It did not deny being in touch with the President or US government , but rejected rumors of an acquisition . 
Hopp said : " I am equally committed to the goal of protecting all people from infections and improving therapies for patients worldwide , ideally curing them , as well as to my intention of creating sustainable innovative infrastructure and jobs in Germany . 
